Alternative cancer cell fuel source targeted as therapeutic approach for breast cancer
New small molecule inhibitor impairs cancer growth in preclinical models by depriving malignant cells of a critical nutrient source
2021-01-07
(Press-News.org) PHILADELPHIA -- (Jan. 7, 2021) -- Scientists at The Wistar Institute characterized an inhibitor that targets acetate metabolism in cancer cells. Cancer cells use acetate metabolism to support tumor growth in conditions of low nutrient and oxygen availability. This molecule caused tumor growth inhibition and regression in preclinical studies, demonstrating the promise of this approach as a novel therapeutic strategy for solid tumors. Study results were published today in Cancer Research, a journal of the American Association for Cancer Research.
Highly proliferating cancer cells within a tumor often experience severe oxygen and nutrient deprivation. Over time, to satisfy their large metabolic demands for energy generation and synthesis of macromolecules, cancer cells adapt and evolve to survive and continue growing using different nutrient sources. The changes that accompany this metabolic rewiring represent a critical barrier to cancer treatment.
The laboratory of Zachary T. Schug, Ph.D., assistant professor in the Molecular & Cellular Oncogenesis Program at The Wistar Institute Cancer Center, studies the metabolic changes that arise during tumor progression to identify targets that can be exploited for new effective cancer treatments.
In particular, they focus on the role of acetate metabolism. They and others have identified acetate as an important alternative nutrient source for cancer cells and discovered that the ACSS2 enzyme, which converts acetate into acetyl-CoA, is crucial for tumor growth under nutrient stress conditions. Acetyl-CoA is an essential metabolite used by cancer cells for many fundamental cellular processes and to generate energy.
"We wanted to verify whether pharmacological inhibition of ACSS2 could prevent tumor growth and offer a significant therapeutic opportunity for cancers that rely on acetate for fuel," said Schug, who is the lead author of the study.
In a collaboration with Joseph Salvino, Ph.D., professor in The Wistar Institute Cancer Center and a medicinal chemistry expert, Schug and colleagues synthesized and tested an inhibitor of the ACSS2 enzyme and showed that this molecule, called VY-3-135, is potent and highly specific in blocking the function of ACSS2 in breast cancer cell lines. Importantly, VY-3-135 treatment was able to inhibit acetate metabolism in tumors in vivo and caused marked inhibition of tumor growth in preclinical breast cancer models with high ACSS2 levels.
"Multiple studies have now shown that ACSS2 is essential in a wide variety of cancers, suggesting that acetate metabolism plays a near universal role in cancer and supports the promise of ACSS2 inhibitors for cancer treatment," said Katelyn D. Miller, Ph.D., postdoctoral fellow in the Schug lab and first author of the study.
"We look forward to furthering our studies and creating safe, potent ACSS2 inhibitors for translation into the clinic," added Schug.
INFORMATION:
Co-authors: Katherine Pniewski, Caroline E. Perry, Sara Papp, Joshua D. Shaffer, Jessica C. Casciano, Tomas M. Aramburu, Yellamelli V.V. Srikanth, Joel Cassel, Emmanuel Skordalakes, Andrew V. Kossenkov, and Joseph M. Salvino from Wistar; Jesse N.Velasco-Silva from University of Utah.
Work supported by: National Institutes of Health grants NIH Director's New Innovator Award DP2 CA249950-01 and T32 CA009171; grants from the W.W. Smith Charitable Trust, Susan G. Komen®, and the V Foundation for Cancer Research. Support for The Wistar Institute facilities was provided by Cancer Center Support Grant P30 CA010815. The Wistar Proteomic and Metabolomic Facility is supported in part by NIH grants R50 CA221838 24 and S10 OD023586.
Publication information: Targeting of ACSS2 with a transition state mimetic inhibits triple negative breast cancer growth, Cancer Research (2021). Online publication.
The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the United States, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-01-07
Scientists who publish in Cell Press research journals (e.g., Cell, Joule, Current Biology, etc.) will now have the option to include a short statement that highlights elements of the study design and/or author characteristics that are relevant to inclusion and diversity. The statement is generated based on information provided on a dedicated inclusion and diversity form that study authors complete as part of the acceptance process. This pilot initiative will also allow Cell Press to better collect, analyze, and share back data about research teams' general inclusion and diversity efforts.
"In an ideal world, science would cover and be ...
2021-01-07
In the early decades of televised news, Americans turned to the stern faces of newsmen like Walter Cronkite, Tom Brokaw, and Dan Rather as trusted sources for news of the important events in America and around the world, delivered with gravitas and measured voices. The rise of comedy-news programs, helmed by the likes of Jon Stewart, Stephen Colbert, John Oliver, Trevor Noah, and Samantha Bee, raised concerns over the blending of entertainment and news. But could the merging of humor and news actually help inform the public?
In fact, new research suggests that humor may help ...
2021-01-07
A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women with a history of injection--including medical purposes and substance use. The findings appear in the journal AIDS Patient Care and STDs.
Currently, most HIV therapies for treatment and prevention (pre-exposure prophylaxis, PrEP) necessitate daily pills, which pose barriers to adherence. Recently, however, LAI for HIV has emerged as an alternative with the potential to boost adherence, although little research has been done on how people with a history of injection feel about these new forms of injectable HIV therapy. There 258,000 women in the United States living with HIV.
The study involved interviews with 89 women across ...
2021-01-07
HOUSTON - (Jan. 7, 2021) - Rice University and Baylor College of Medicine researchers have found a way to mimic conditions in intestines, giving them a mechanical model for the real-time growth of bacterial infections.
In a new study, they demonstrate a lab tool that simplifies simulations of the human intestine, making it more practical to find treatments for diseases like infectious diarrhea.
The team led by bioengineer Jane Grande-Allen of Rice's Brown School of Engineering developed transparent millifluidic perfusion cassettes (mPCs) that are easy to fabricate and operate and compatible with common microscopic and biochemical analysis.
The cassettes allow even non-bioengineers to perform the kind of studies ...
2021-01-07
Jülich, Germany, 7 January 2021. The Kondo effect influences the electrical resistance of metals at low temperatures and generates complex electronic and magnetic orders. Novel concepts for data storage and processing, such as using quantum dots, are based on this. In 1998, researchers from the United States published spectroscopic studies on the Kondo effect using scanning tunnelling microscopy, which are considered ground-breaking and have triggered countless others of a similar kind. Many of these studies may have to be re-examined now that Jülich researchers have shown that the Kondo effect cannot be proven beyond doubt ...
2021-01-07
As the first doses of COVID-19 vaccines are being rolled out, it is still unclear whether enough Americans are willing to be vaccinated to allow the nation to return to normalcy. Many believe a key part of the equation lies in how effective vaccine communication teams are at convincing the public to get vaccinated. And the key to effective communication tactics in promoting the vaccines may lie in demonstrated behavioral economics and consumer behavior theory, experts say.
"The country has made an incredible investment in fast-tracking SARS-CoV-2 vaccines from conception to market, which would make it even more tragic if we fail to curtail the virus simply because Americans ...
2021-01-07
Philadelphia, January 7, 2021 - A new study in the Journal of Nutrition Education and Behavior, published by Elsevier, explores real-time personal and employee safety experiences and perspectives of school nutrition professionals ranging from frontline staff to state leadership across the United States during the early weeks of the coronavirus pandemic.
A survey with both closed- and open-ended items was developed to explore the experiences of school nutrition staff, managers, directors, and state agency personnel. Descriptive statistics from the responses of 47 states ...
2021-01-07
The COVID-19 pandemic has seen hardware developers clamouring to make 'open source' technology to support our frontline services. Their intentions have been honourable - an invitation to teams across the world to collaborate in developing essential equipment such as ventilators, thereby making the process of producing critical instruments more effective, both in time and cost.
In practice, however, most developers of hardware have shown little 'openness' in their sharing of designs, a fact lamented by a group of physicists from the University of Bath in the UK, in a paper published this week in The Design Journal.
According to the group, the pandemic has ...
2021-01-07
Whenever an organism develops and forms organs, a tumour creates metastases or the immune system becomes active in inflammation, cells migrate within the body. As they do, they interact with surrounding tissues which influence their function. The migrating cells react to biochemical signals, as well as to biophysical properties of their environment, for example whether a tissue is soft or stiff. Gaining detailed knowledge about such processes provides scientists with a basis for understanding medical conditions and developing treatment approaches.
A team of biologists and mathematicians at the Universities of Münster and Erlangen-Nürnberg has now developed a new method for analysing cell migration ...
2021-01-07
Engineering researchers have developed a new technique for eliminating particularly tough blood clots, using engineered nanodroplets and an ultrasound "drill" to break up the clots from the inside out. The technique has not yet gone through clinical testing. In vitro testing has shown promising results.
Specifically, the new approach is designed to treat retracted blood clots, which form over extended periods of time and are especially dense. These clots are particularly difficult to treat because they are less porous than other clots, making it hard for drugs ...
LAST 30 PRESS RELEASES:
[Press-News.org] Alternative cancer cell fuel source targeted as therapeutic approach for breast cancer
New small molecule inhibitor impairs cancer growth in preclinical models by depriving malignant cells of a critical nutrient source
